HIV-1, antiretroviral therapy, and malaria.
Rogerson
Stephen
S
Department of Medicine (RMH/WH), University of Melbourne, Royal Melbourne Hospital, VIC 3050, Parkville, Australia. sroger@unimelb.edu.au
D000328:Adult; D000367:Age Factors; D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018955:CD36 Antigens / Q000276:immunology; D002648:Child; D015897:Comorbidity; D004359:Drug Therapy, Combination; D004912:Erythrocytes / Q000276:immunology / Q000469:parasitology; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000276:immunology; D016778:Malaria, Falciparum / Q000097:blood / Q000453:epidemiology* / Q000469:parasitology; D018512:Parasitemia / Q000453:epidemiology; D010963:Plasmodium falciparum / Q000276:immunology / Q000469:parasitology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D015800:Protozoan Proteins / Q000276:immunology; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D019562:Viral Load
D019380:Anti-HIV Agents; D018955:CD36 Antigens; D017320:HIV Protease Inhibitors; D015800:Protozoan Proteins; D018894:Reverse Transcriptase Inhibitors; C085731:erythrocyte membrane protein 1, Plasmodium falciparum; D018799:Intercellular Adhesion Molecule-1